Agilent Technologies Signs Agreement to Acquire Stratagene Corp., a Developer of Life Science Resear

Agilent Technologies Inc. (NYSE: A) today announced that it has signed a definitive agreement with Stratagene Corp. (NASDAQ: STGN) to acquire the developer, manufacturer and marketer of specialized life science research and diagnostic products.

Source: Agilent Technologies Inc.